Lyra Therapeutics
NASDAQ: LYRA
Healthcare
Biotechnology
Rank
#41959
Market Cap
6.64 M
Volume
107,593
Price
5.01
Change (%)
0.00%
Country or region
United States
United States
Lyra Therapeutics Stock Split History Overview
This company has undergone a total of one stock splits throughout its history. One reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on 05/28/2025 with a ratio of 1-for-50. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
Lyra Therapeutics (NASDAQ: LYRA) Stock Split History
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| 05/28/2025 | 1:50 | x0.02 | x0.02 | Reverse |
Frequently Asked Questions
If Lyra Therapeutics (stock symbol: NASDAQ: LYRA) had never undergone any stock splits, its price per share today would be approximately 0.10 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-50) that occurred on 05/28/2025.
Lyra Therapeutics (stock symbol: NASDAQ: LYRA) has undergone a total of one stock splits. The most recent split occurred on 05/28/2025. One share bought prior to the first split on 05/28/2025 would now equal 0.02 shares.
Lyra Therapeutics (stock symbol: NASDAQ: LYRA) has undergone one stock splits in its history. The most recent split, a 1-for-50 split, occurred on 05/28/2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.
